Xylopic acid-amodiaquine and xylopic acid-artesunate combinations are effective in managing malaria in Plasmodium berghei-infected mice.

Background: Evidence of Plasmodium resistance to some of the current anti-malarial agents makes it imperative to search for newer and effective drugs to combat malaria. Therefore, this study evaluated whether the co-administrations of xylopic acid-amodiaquine and xylopic acid-artesunate combinations will produce a synergistic anti-malarial effect.

Methods: Antiplasmodial effect of xylopic acid (XA: 3, 10, 30, 100, 150 mg kg), artesunate (ART: 1, 2, 4, 8, 16 mg kg), and amodiaquine (AQ: 1.